Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Jan 27;9(1):e85554.
doi: 10.1371/journal.pone.0085554. eCollection 2014.

Survival of adults with acute lymphoblastic leukemia in Germany and the United States

Dianne Pulte  1 , Lina Jansen  2 , Adam Gondos  2 , Alexander Katalinic  3 , Benjamin Barnes  4 , Meike Ressing  5 , Bernd Holleczek  6 , Andrea Eberle  7 , Hermann Brenner  8 ; GEKID Cancer Survival Working Group
Collaborators, Affiliations
Comparative Study

Survival of adults with acute lymphoblastic leukemia in Germany and the United States

Dianne Pulte et al. PLoS One. .

Abstract

Background: Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to childhood ALL, survival for adults with ALL is poor. Recently, new protocols, including use of pediatric protocols in young adults, have improved survival in clinical trials. Here, we examine population level survival in Germany and the United States (US) to gain insight into the extent to which changes in clinical trials have translated into better survival on the population level.

Methods: Data were extracted from the Surveillance, Epidemiology, and End Results database in the US and 11 cancer registries in Germany. Patients age 15-69 diagnosed with ALL were included. Period analysis was used to estimate 5-year relative survival (RS).

Results: Overall 5-year RS was estimated at 43.4% for Germany and 35.5% for the US (p = 0.004), with a decrease in survival with increasing age. Survival was higher in Germany than the US for men (43.6% versus 37.7%, p = 0.002) but not for women (42.4% versus 40.3%, p>0.1). Five-year RS estimates increased in Germany and the US between 2002 and 2006 by 11.8 and 7.3 percent units, respectively (p = 0.02 and 0.04, respectively).

Conclusions: Survival for adults with ALL continues to be low compared with that for children, but a substantial increase in 5-year survival estimates was seen from 2002 to 2006 in both Germany and the US. The reasons for the survival differences between both countries require clarification.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

References

    1. Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166–78. - PubMed
    1. Pulte D, Gondos A, Brenner H (2008) Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990–2004. J Natl Cancer Inst. 100(18): 1301–9. - PubMed
    1. Pulte D, Gondos A, Brenner H (2009) Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States 1981–2005. Cancer 115(21): 4973–9. - PubMed
    1. Pulte D, Gondos A, Brenner H (2009) Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood 113(7): 1408–11. - PubMed
    1. Fielding A (2008) The treatment of adults with acute lymphoblastic leukemia. Hematology 381–9. - PubMed

Publication types

LinkOut - more resources